APA (7th ed.) Citation

LN, C., PJ, H., CC, C., WT, C., CJ, C., LL, T., . . . TC, F. (2025). Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan. International journal of medical sciences, 22(6), 1404. https://doi.org/10.7150/ijms.103390

Chicago Style (17th ed.) Citation

LN, Chien, Hsiao PJ, Chiu CC, Chen WT, Cheng CJ, Tsou LL, Kao YH, Chou CL, and Fang TC. "Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan." International Journal of Medical Sciences 22, no. 6 (2025): 1404. https://doi.org/10.7150/ijms.103390.

MLA (9th ed.) Citation

LN, Chien, et al. "Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan." International Journal of Medical Sciences, vol. 22, no. 6, 2025, p. 1404, https://doi.org/10.7150/ijms.103390.